Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

Volitionrx Ltd

In Vitro & In Vivo Diagnostic Substances · Henderson, NV, United States

  1. PrincipalsAndrew RetterChief Medical OfficerAnn-Louise BatchelorGroup Chief Marketing OfficerCameron John ReynoldsPresident and CEOand 15 more
  2. CompanyVolitionrx LtdHenderson, NV, United States
  3. Phone line+1 (512) 774-8930General business
Request a quote

Volitionrx Ltd is an SEC-registered NYSE-listed company (ticker VNRX) classified under SIC 2835: In Vitro & In Vivo Diagnostic Substances.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2835 — In Vitro & In Vivo Diagnostic Substances — SEC EDGAR company submissions

People 18

Chief executive

Cameron John ReynoldsPresident and CEO
Jasmine KwayCEO - Singapore Volition
Salvatore Thomas ButeraCEO - Volition Veterinary

Chair & board

Alan ColmanDirector (Board)
Ethel RubinDirector (Board)
Guy Archibald InnesDirector (Board)
Kim NguyenDirector (Board)

Finance

Terig HughesChief Financial Officer

Operations

Gaetan MichelChief Operating Officer

Sales & commercial

Gael ForterreChief Commercial Officer
Everyone else on file (4)
Andrew RetterChief Medical Officer
Ann-Louise BatchelorGroup Chief Marketing Officer
Jacob Vincent MicallefChief Scientific Officer
Nicholas PlummerGC - Volition Diagnostics

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Ann-Louise Batchelor — Group Chief Marketing Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Cameron John Reynolds — President and CEO

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Gael Forterre — Chief Commercial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  5. Andrew Retter — Chief Medical Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers